Drug Insights

Harnessing Synapse for Acetaminophen Information: Strategies and Tips

1 February 2024
2 min read

Acetaminophen, a small molecule drug that operates as a COX enzyme inhibitor, was granted its first approval in January 1966, and is commonly used to alleviate pain and reduce fever as an analgesic and antipyretic medication. This multifaceted drug is prescribed for an extensive range of conditions, including headaches, toothaches, acute pain, and pharmaceutical aid. Additionally, it is applied as a treatment for altitude sickness, a condition brought about by exposure to high altitudes. The COX enzyme is targeted by acetaminophen, which results in a reduction of prostaglandins production. Prostaglandins are chemicals responsible for inflammation, pain, and fever. Acetaminophen is usually well-tolerated with limited side effects when taken at the recommended dosage. However, if taken in large doses, acetaminophen may cause liver damage. Click on the image below to begin the exploration journey of Acetaminophen through the Synapse database!

图形用户界面, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Locus Biosciences Secures $23.9M BARDA Investment for Phase 2 of Groundbreaking CRISPR Phage Treatment
Latest Hotspot
3 min read
Locus Biosciences Secures $23.9M BARDA Investment for Phase 2 of Groundbreaking CRISPR Phage Treatment
1 February 2024
Locus Biosciences has disclosed receiving a $23.9 million investment from BARDA, intended to back the inaugural Phase 2 study of its groundbreaking CRISPR-crafted phage treatment.
Read →
Effortless Searching: How to Find Metronidazole on Synapse
Drug Insights
2 min read
Effortless Searching: How to Find Metronidazole on Synapse
1 February 2024
Metronidazole, a small molecule drug approved in 1960 by Pfizer Inc., inhibits DNA synthesis and is highly effective against anaerobic bacteria and protozoa.
Read →
Onward Therapeutics Starts Recruiting for OT-A201 Dual-Targeted Antibody Clinical Study
Latest Hotspot
3 min read
Onward Therapeutics Starts Recruiting for OT-A201 Dual-Targeted Antibody Clinical Study
1 February 2024
Onward Therapeutics has begun recruiting for an initial phase clinical study of their innovative dual-targeted antibody, OT-A201, which engages with two distinct immune control points.
Read →
Making the Most Out of Synapse: Searching for Pantoprazole
Drug Insights
2 min read
Making the Most Out of Synapse: Searching for Pantoprazole
1 February 2024
Pantoprazole is a small molecule medicine classed as a proton pump inhibitor, which means it reduces the amount of acid generated in the stomach.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.